PPA: Clinical Trials

1 trial for PPA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow PPA: new trials by email Literature Review of PPA trials Research Report on PPA

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
AV-1451 - PPA, Non-fluent Aphasia
Phase 4RecruitingMayo Clinic502018-07-012025-11-12

Narrower conditions

Aphasia (1)  ·  Aphasia, Broca (1)  ·  Aphasia, Primary Progressive (1)  ·  Apraxias (1)  ·  Primary Progressive Nonfluent Aphasia (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Communication Disorders (1)  ·  Dementia (1)  ·  Frontotemporal Lobar Degeneration (1)  ·  Language Disorders (1)  ·  Mental Disorders (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurocognitive Disorders (1)  ·  Neurodegenerative Diseases (1)  ·  Neurologic Manifestations (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (1)

Sponsors

Mayo Clinic (1)

Countries

United States (1)

Top investigators

Jennifer Whitwell, PhD (1)

NIH funding

R01DC012519 (1)